Is UNH a good stock to buy? We came across a bullish thesis on UnitedHealth Group Incorporated on MaxDividends’s Substack by Serhio MaxDividends. In this article, we will summarize the bulls’ thesis on UNH. UnitedHealth Group Incorporated’s share was trading at $ 316.40 as of April 16th. UNH’s trailing and forward P/E were 23.74 and 17.67 respectively according to Yahoo Finance.
alexkich/Shutterstock.com
UnitedHealth Group (UNH) stands out as a diversified healthcare giant leveraging its massive scale across insurance, care delivery, pharmacy services, and data analytics to generate resilient and growing cash flows. Through its two core platforms—UnitedHealthcare and Optum—the company serves tens of millions of members while simultaneously monetizing services across the broader healthcare ecosystem, creating multiple profit pools that reduce reliance on any single segment.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
This integrated model has enabled consistent operating leverage, strong recurring cash generation, and a shareholder-friendly capital return profile, highlighted by a 3.25% dividend yield, a $8.84 annual dividend, and 16 consecutive years of dividend increases, alongside an elevated but manageable 67% payout ratio that still allows for reinvestment in growth initiatives.
Financially, the company delivered robust 2025 results, with revenue reaching $447.6 billion (+12% YoY), adjusted EPS of $16.35, and operating cash flow of $19.7 billion, demonstrating strong earnings quality and cash conversion. UnitedHealthcare grew revenue 16% to $344.9 billion, serving nearly 50 million members, while Optum generated $270.6 billion in revenue, supporting over 123 million individuals, reinforcing the breadth and scalability of its platform.
Looking ahead, management guides for continued expansion with 2026 revenue expected above $439 billion and adjusted EPS exceeding $17.75, supported by disciplined cost control, medical care ratio management, and ongoing investments in AI-driven efficiencies and service expansion.
Despite regulatory and reimbursement risks inherent to the sector, UnitedHealth’s scale, diversification, and consistent cash generation position it as a high-quality compounder, offering investors a compelling combination of income, growth, and durability.
Previously, we covered a bullish thesis on UnitedHealth Group Incorporated (UNH) by FluentInQuality in May 2025, which highlighted the company’s scale advantages, Medicare growth opportunity, strong return metrics, and vertical integration through Optum. UNH’s stock price has appreciated by approximately 7.25% since our coverage. Serhio MaxDividends shares a similar view but emphasizes on dividend strength and cash flow visibility.
UnitedHealth Group Incorporated is on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 145 hedge fund portfolios held UNH at the end of the fourth quarter which was 140 in the previous quarter. While we acknowledge the risk and potential of UNH as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than UNH and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
